Cargando…

Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists

Pulmonary vascular tone is modulated by nucleotides, but which P2 receptors mediate these actions is largely unclear. The aim of this study, therefore, was to use subtype-selective antagonists to determine the roles of individual P2Y receptor subtypes in nucleotide-evoked pulmonary vasodilation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dales, Markie O., Mitchell, Callum, Gurney, Alison M., Drummond, Robert M., Kennedy, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832182/
https://www.ncbi.nlm.nih.gov/pubmed/36018534
http://dx.doi.org/10.1007/s11302-022-09895-x
_version_ 1784868006652805120
author Dales, Markie O.
Mitchell, Callum
Gurney, Alison M.
Drummond, Robert M.
Kennedy, Charles
author_facet Dales, Markie O.
Mitchell, Callum
Gurney, Alison M.
Drummond, Robert M.
Kennedy, Charles
author_sort Dales, Markie O.
collection PubMed
description Pulmonary vascular tone is modulated by nucleotides, but which P2 receptors mediate these actions is largely unclear. The aim of this study, therefore, was to use subtype-selective antagonists to determine the roles of individual P2Y receptor subtypes in nucleotide-evoked pulmonary vasodilation and vasoconstriction. Isometric tension was recorded from rat intrapulmonary artery rings (i.d. 200–500 µm) mounted on a wire myograph. Nucleotides evoked concentration- and endothelium-dependent vasodilation of precontracted tissues, but the concentration–response curves were shallow and did not reach a plateau. The selective P2Y(2) antagonist, AR-C118925XX, inhibited uridine 5′-triphosphate (UTP)- but not adenosine 5′-triphosphate (ATP)-evoked relaxation, whereas the P2Y(6) receptor antagonist, MRS2578, had no effect on UTP but inhibited relaxation elicited by uridine 5′-diphosphate (UDP). ATP-evoked relaxations were unaffected by the P2Y(1) receptor antagonist, MRS2179, which substantially inhibited responses to adenosine 5′-diphosphate (ADP), and by the P2Y(12/13) receptor antagonist, cangrelor, which potentiated responses to ADP. Both agonists were unaffected by CGS1593, an adenosine receptor antagonist. Finally, AR-C118925XX had no effect on vasoconstriction elicited by UTP or ATP at resting tone, although P2Y(2) receptor mRNA was extracted from endothelium-denuded tissues using reverse transcription polymerase chain reaction with specific oligonucleotide primers. In conclusion, UTP elicits pulmonary vasodilation via P2Y(2) receptors, whereas UDP acts at P2Y(6) and ADP at P2Y(1) receptors, respectively. How ATP induces vasodilation is unclear, but it does not involve P2Y(1), P2Y(2), P2Y(12), P2Y(13), or adenosine receptors. UTP- and ATP-evoked vasoconstriction was not mediated by P2Y(2) receptors. Thus, this study advances our understanding of how nucleotides modulate pulmonary vascular tone.
format Online
Article
Text
id pubmed-9832182
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-98321822023-01-12 Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists Dales, Markie O. Mitchell, Callum Gurney, Alison M. Drummond, Robert M. Kennedy, Charles Purinergic Signal Original Article Pulmonary vascular tone is modulated by nucleotides, but which P2 receptors mediate these actions is largely unclear. The aim of this study, therefore, was to use subtype-selective antagonists to determine the roles of individual P2Y receptor subtypes in nucleotide-evoked pulmonary vasodilation and vasoconstriction. Isometric tension was recorded from rat intrapulmonary artery rings (i.d. 200–500 µm) mounted on a wire myograph. Nucleotides evoked concentration- and endothelium-dependent vasodilation of precontracted tissues, but the concentration–response curves were shallow and did not reach a plateau. The selective P2Y(2) antagonist, AR-C118925XX, inhibited uridine 5′-triphosphate (UTP)- but not adenosine 5′-triphosphate (ATP)-evoked relaxation, whereas the P2Y(6) receptor antagonist, MRS2578, had no effect on UTP but inhibited relaxation elicited by uridine 5′-diphosphate (UDP). ATP-evoked relaxations were unaffected by the P2Y(1) receptor antagonist, MRS2179, which substantially inhibited responses to adenosine 5′-diphosphate (ADP), and by the P2Y(12/13) receptor antagonist, cangrelor, which potentiated responses to ADP. Both agonists were unaffected by CGS1593, an adenosine receptor antagonist. Finally, AR-C118925XX had no effect on vasoconstriction elicited by UTP or ATP at resting tone, although P2Y(2) receptor mRNA was extracted from endothelium-denuded tissues using reverse transcription polymerase chain reaction with specific oligonucleotide primers. In conclusion, UTP elicits pulmonary vasodilation via P2Y(2) receptors, whereas UDP acts at P2Y(6) and ADP at P2Y(1) receptors, respectively. How ATP induces vasodilation is unclear, but it does not involve P2Y(1), P2Y(2), P2Y(12), P2Y(13), or adenosine receptors. UTP- and ATP-evoked vasoconstriction was not mediated by P2Y(2) receptors. Thus, this study advances our understanding of how nucleotides modulate pulmonary vascular tone. Springer Netherlands 2022-08-26 2022-12 /pmc/articles/PMC9832182/ /pubmed/36018534 http://dx.doi.org/10.1007/s11302-022-09895-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Dales, Markie O.
Mitchell, Callum
Gurney, Alison M.
Drummond, Robert M.
Kennedy, Charles
Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists
title Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists
title_full Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists
title_fullStr Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists
title_full_unstemmed Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists
title_short Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists
title_sort characterisation of p2y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832182/
https://www.ncbi.nlm.nih.gov/pubmed/36018534
http://dx.doi.org/10.1007/s11302-022-09895-x
work_keys_str_mv AT dalesmarkieo characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists
AT mitchellcallum characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists
AT gurneyalisonm characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists
AT drummondrobertm characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists
AT kennedycharles characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists